We are live on
!
Find out more
AAF
Andra AP-fonden Portfolio holdings
AUM
$8.39B
1-Year Est. Return
21.19%
This Fund
S&P 500
This Quarter
Est. Return
+1.92%
1 Year Est. Return
+21.19%
3 Year Est. Return
+70.53%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.95B
AUM Growth
+$319M
(+5.7%)
Cap. Flow
+$251M
Cap. Flow
% of AUM
4.22%
Top 10 Holdings %
Top 10 Hldgs %
16.32%
Holding
451
New
88
Increased
179
Reduced
148
Closed
36
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$40.5M |
| 2 |
Accenture
ACN
|
+$35.3M |
| 3 |
NXP Semiconductors
NXPI
|
+$34.2M |
| 4 |
Meta Platforms (Facebook)
META
|
+$26.6M |
| 5 |
JPMorgan Chase
JPM
|
+$23.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$55.3M |
| 2 |
Broadcom
AVGO
|
+$42.3M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$29.8M |
| 4 |
Microsoft
MSFT
|
+$27M |
| 5 |
Home Depot
HD
|
+$26.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.56% |
| 2 | Healthcare | 14.4% |
| 3 | Consumer Discretionary | 10.02% |
| 4 | Financials | 9.97% |
| 5 | Industrials | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Synchrony
SYF
$25.6B
| $8.68M | 0.15% |
183,900
-92,300
| -33% | -$4.01M |
|
227
Ventas
VTR
$47.3B
| $8.63M | 0.14% |
168,300
+37,900
| +29% | +$1.77M |
|
228
VeriSign
VRSN
$26.4B
| $8.57M | 0.14% |
48,200
-7,800
| -14% | -$1.39M |
|
229
CME Group
CME
$95B
| $8.41M | 0.14% |
42,800
+34,900
| +442% | +$7.21M |
|
230
Avantor
AVTR
$8.91B
| $8.39M | 0.14% |
395,900
+13,400
| +4% | +$323K |
|
231
Lattice Semiconductor
LSCC
$18.3B
| $8.35M | 0.14% |
144,000
+26,667
| +23% | +$1.84M |
|
|
FISV
232
Fiserv Inc
FISV
$28.9B
| $8.24M | 0.14% |
55,295
+4,900
| +10% | +$742K |
|
233
West Pharmaceutical
WST
$24.5B
| $8.23M | 0.14% |
25,000
+4,700
| +23% | +$1.66M |
|
234
Fidelity National Financial
FNF
$14.1B
| $8.21M | 0.14% |
166,200
-32,400
| -16% | -$1.63M |
|
235
Verisk Analytics
VRSK
$24.7B
| $7.82M | 0.13% |
29,000
-36,600
| -56% | -$8.96M |
|
236
T. Rowe Price
TROW
$24.2B
| $7.81M | 0.13% |
67,700
-14,600
| -18% | -$1.68M |
|
237
Graco
GGG
$13.5B
| $7.79M | 0.13% |
98,200
+67,600
| +221% | +$5.66M |
|
238
Burlington
BURL
$23.4B
| $7.75M | 0.13% |
32,300
+9,700
| +43% | +$2M |
|
239
Edwards Lifesciences
EW
$51.5B
| $7.74M | 0.13% |
83,800
+46,700
| +126% | +$4.14M |
|
240
Chubb
CB
$137B
| $7.45M | 0.13% |
+29,200
| New | +$7.5M |
|
241
UDR
UDR
$12.3B
| $7.35M | 0.12% |
178,500
-156,500
| -47% | -$6.03M |
|
242
Old Dominion Freight Line
ODFL
$44B
| $7.31M | 0.12% |
41,400
+15,600
| +60% | +$2.94M |
|
243
Palantir
PLTR
$375B
| $7.25M | 0.12% |
286,400
+157,400
| +122% | +$3.54M |
|
244
Qorvo
QRVO
$8.41B
| $7.19M | 0.12% |
62,000
-26,300
| -30% | -$2.8M |
|
245
Mid-America Apartment Communities
MAA
$15.5B
| $7.1M | 0.12% |
49,800
-26,500
| -35% | -$3.54M |
|
|
HOLX
246
DELISTED
Hologic
HOLX
| $7.08M | 0.12% |
95,400
+66,000
| +224% | +$4.95M |
|
247
Cincinnati Financial
CINF
$27.5B
| $7.06M | 0.12% |
59,800
+9,400
| +19% | +$1.1M |
|
248
Agnico Eagle Mines
AEM
$85B
| $7.06M | 0.12% |
+78,922
| New | +$5.15M |
|
249
Franco-Nevada
FNV
$44.6B
| $6.97M | 0.12% |
+43,000
| New | +$5.23M |
|
250
Zillow
Z
$7.65B
| $6.97M | 0.12% |
150,300
+66,200
| +79% | +$2.91M |
|
Similar funds
NW
QC
GGHC
FT
DM
GRQ
PCM
IC
Andra AP-fonden's Q2 2024 Portfolio in Review
As of Q2 2024, Andra AP-fonden held 451 positions worth $5.95B, up 5.7% from $5.63B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Andra AP-fonden deployed $251M of net new capital in Q2 2024, opening 88 new positions and adding to 179 existing holdings. Its largest new stake was Accenture: 115,208 shares worth $35M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Broadcom, an estimated $42.3M trimmed.
- Andra AP-fonden's largest Q2 2024 buy was Accenture: 115,208 shares worth $35M.
- Andra AP-fonden added most to Johnson & Johnson in Q2 2024, an estimated $40.5M increase.
- Andra AP-fonden's biggest Q2 2024 reduction was Broadcom, cutting an estimated $42.3M.
- Andra AP-fonden fully exited Bristol-Myers Squibb in Q2 2024, selling an estimated $55.3M.
- Andra AP-fonden's ten largest holdings make up 16% of its $5.95B portfolio in Q2 2024.
- Andra AP-fonden opened 88 new positions and closed 36 in Q2 2024.
- Andra AP-fonden's portfolio value rose 5.7% quarter-over-quarter to $5.95B.
Based on Andra AP-fonden's 13F filing for Q2 2024, filed 7 Aug 2024.